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ABSTRACT 
Genomic imprinting is a process that leads to the silencing of one allele of a gene in a parent of 
origin specific manner.  Genes that are involved in this process are often regulated in clusters, one of 
which is the Peg3 (Paternally expressed gene 3) imprinted domain.  We investigated this region for both 
CpG islands and long antisense transcripts, two common features of imprinted gene clusters.  
First, we performed a systematic survey of DNA methylation status of the CpG islands in this 
region of the mouse, cow, and human genomes.  We identified two previously unreported differentially 
methylated regions (DMR): one in the promoter region of mouse Zim3 and another in the promoter region 
of human USP29.  The PEG3-CpG island is the only DMR that is conserved among these three species.  
PEG3 has been implicated in several types of cancer, so we examined the methylation status of several 
CpG islands in this region using human tumor derived DNA.  The CpG islands near PEG3 and USP29 
both showed hypermethylation in DNA derived from breast and ovarian tumors.  Second, we identified an 
antisense transcript to ZIM2 (zinc finger imprinted gene 2) called ZIM2as in the human, chimpanzee, and 
orangutan.  In non-primate mammals, the 5’ side of the Peg3 imprinted domain is bounded by a cluster of 
olfactory receptor (OLFR) genes which may curtail the spread of imprinting.  We report the presence of 
two previously unreported DMRs near the ZIM2as promoter region.  The CpG island distal to ZIM2as 
was methylated allele-specifically in the human testis, while the CpG island proximal to the ZIM2as 
promoter showed a mosaic methylation pattern in the chimpanzee.  Two CpG islands near the promoter 
region of ZIM2as showed different methylation patterns in these three species.   
Overall, this work provides a firm foundation for future studies of the Peg3 imprinted domain.  It 
represents the first systematic study of DNA methylation in the Peg3 imprinted region.  It also describes 
an antisense transcript that has formed in the great ape PEG3 imprinted domain which may control the 
extension of this imprinted domain. 
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CHAPTER ONE: BACKGROUND 
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Genomic Imprinting 
Most autosomal genes are expressed equally from two parental alleles, but up to 200 mammalian 
genes are only transcribed from one allele based on the parent of origin due to the genomic imprinting 
process (Ideraabdullah et al., 2008).  Genomic imprinting is found only in marsupials and placental 
mammals, organisms that utilize a unique reproductive strategy in which young offspring develop inside 
females’ wombs.  The phenomenon of genomic imprinting was discovered in 1984 after the failure of 
nuclear transfer experiments to produce either androgenetic or parthenogenetically derived mice (Surani 
et al., 1984).  The most prevalent explanation for the evolution of genomic imprinting is the conflict 
theory (Moore and Reik, 1996).  To maximize fitness, it is in the male’s best interest to ensure that his 
offspring receive the most nutrients, but the female’s interest lies in maximizing the number of offspring 
(spreading the resources among her children).  Consistent with this, many imprinted genes are involved in 
controlling fetal growth rates and nurturing behaviors (Tilghman, 1999).  Maternally expressed genes are 
often growth suppressors, and paternally expressed genes are often growth inducers.  The proper dosage 
of imprinted genes is critical for the survival of mammals, and abnormalities in the dosages quite often 
manifest as genetic diseases in humans.  Imprinting-related diseases include Beckwith-Wiedemann, 
Prader/Willi, Angelman, and Silver-Russell syndromes as well as autistic spectrum disorders (Ferguson-
Smith et al., 2004; Ideraabdullah et al., 2008).   
Imprinted genes often exist in clusters that are regulated by one or a few imprinting control 
regions (ICRs) (Edwards and Ferguson-Smith, 2007), which control the monoallelic expression of 
multiple genes within the cluster.  One common feature of imprinted domains is the expression of 
antisense transcripts that regulate imprinting (Pauler et al., 2007).  Antisense transcripts are a frequent part 
of the regulatory machinery of imprinted domains.  For example, Air, an antisense transcript to Igf2r, is 
required to maintain monoallelic expression of Igf2r.  Disruption of Air causes Igf2r to lose imprinting 
and become expressed from both alleles (Sleutels, et al., 2002).  The mechanisms by which antisense 
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transcripts silence genes are mostly unknown, but Air has been shown to interact with G9a, a histone 3 
lysine 9 methyltransferase (Nagano et al., 2008). G9a has been shown to interact with DNA 
methyltransferases (Esteve et al., 2006).  Thus, antisense transcripts in imprinted regions may target 
repressive modifiers to silence transcription from one allele. 
Another common feature of imprinted domains is the presence of CpG islands with allele-specific 
DNA methylation patterns (also called differentially methylated regions: DMR) (Ferguson-Smith et al., 
2004).  Some of these DMRs inherit their methylation as a gametic signal from the previous generations, 
and these DMRs play critical roles for maintaining the imprinting and transcription of a given domain 
(Edwards and Ferguson-Smith, 2007).  Abnormal methylation levels of these DMRs, either 
hypermethylation or hypomethylation, are also often associated with many types of human diseases as 
‘epimutations’ (Hatchwell and Greally, 2007).  There are two periods of DNA demethylation and 
remethylation that occur during mammalian development.  The first occurs around the time of 
implantation, and the second occurs in the primordial germ cells that will eventually produce gametes 
(Lees-Murdock and Walsh, 2008).  This second round of DNA methylation setting ensures that the future 
gametes will have the correct regulation of imprinted genes for their gender.    
DNA Methylation 
During the early studies of DNA, several modified bases were found to be present in low 
concentrations in addition to the four that make up the majority.  In mammals, the most prevalent minor 
base is 5-methyl cytosine, which only occurs within the context of a CpG (cytosine-phosphodiester bond-
guanine) dinucleotide.  DNA methylation of a gene’s promoter generally leads to transcriptional 
inactivation.  The formation of 5-methyl cytosine is achieved by the transfer of a methyl group from S-
adenosyl methionine to a cytosine by a DNA methyltransferase enzyme (Bird, 2002). (Fig 1.1) There are 
two related de novo methyltransferases: Dnmt3a and Dnmt3b, and a related non-catalytic protein, Dnmt3l 
that is highly expressed in the male germline.  Dnmt3l forms a complex with Dnmt3a and/or Dntm3b and 
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appears to act as an adapter to target DNA methylation to specific regions.  Disruption of Dnmt3l causes 
hypomethylation of transposable elements and prevents spermatocytes from completing development 
(Bourc’his and Bestor, 2004). Knockout of either Dnmt3a or Dnmt3b is lethal, but knockout of Dnmt3b  
specifically in the germline shows no obvious phenotype; mice with a germline knockout of Dnmt3a are 
healthy but cannot produce live offspring (Kaneda et al., 2004).   
Fig 1.1. The DNA methylation reaction.   
Dnmt1, the DNA maintenance methyltransferase, has a higher affinity for DNA that is methylated 
on one strand only, as a product of the semiconservative replication of DNA (Bird, 2002).  In this case, 
the parent strand received methylation prior to the initiation of replication (either from a de novo 
methyltransferase or from a maintenance methyltransferase in a previous round of replication), and the 
daughter strand is methylation-free.  Dnmt1 is also necessary for maintaining the correct methylation 
pattern in imprinted regions (Hirasawa et al., 2008).   
Proper DNA methylation is essential for survival in mammals and the majority of DNA in the 
mammalian genome is methylated.  The major exception to this rule is the CpG islands, which feature a 
higher than expected prevalence of the CpG dinucleotide (cytosine followed immediately by guanine).  
Since methylated cytosine has a high rate of mutation to thymine, CpG sites that are constitutively 
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methylated will decay to TpG or CpA, reducing the prevalence of CpG dinucleotides (Bird, 1996).  Loss 
of DNA methylation leads to global derepression of transposable elements and chromosomal 
rearrangements.  This effect suggests that DNA methylation may have evolved as a defense against 
transposable elements (Yoder et al., 1997).  In addition to the repression of transposable elements, DNA 
methylation is also important in the monoallelic expression characteristic of the genomic imprinting 
process.  Without expression of DNA methyltransferases, imprinted regions revert to biallelic expression 
(Kaneda et al., 2004; Hirasawa et al., 2008).   
Techniques for DNA Methylation Analysis 
There are several different methods used to study the location and extent of DNA methylation.  
One of the most sensitive methods uses a Southern blot in which a DNA sample is split and each fraction 
is digested with one of two restriction enzymes (Southern, 2006).  One of these enzymes is inhibited by 
the presence of CpG methylation and the other is not inhibited by this modification.  The blot is then 
probed with DNA complementary to the region of interest and the size of the band reveals the methylation 
status.  If the fragment is the same size in both fractions, the DNA is unmethylated, but if the fragment is 
larger in the methylation-sensitive digest, the DNA is methylated.  This method is very sensitive, but has 
the limitation of detecting methylation only at the specific site recognized by the restriction enzyme. 
  Several other techniques are based on the bisulfite conversion method.  This chemical conversion 
method changes any unmethylated cytosines to uracil, while leaving methylated cytosines intact (Clark et 
al., 1994).  After bisulfite conversion, the DNA is amplified by PCR and the uracil is replaced with 
thymine (Fig. 1.2).  The resulting bisulfite PCR product can be analyzed by using a restriction enzyme 
that will differentiate between the methylated and unmethylated DNA based on the sequence differences 
that exist after bisulfite conversion (Xiong and Laird, 1997).  An enzyme that has a CpG within its 
recognition site is generally used.  The recognition site will be preserved only in methylated DNA, so 
only methylated DNA will be digested.  This method, the combined bisulfite restriction analysis 
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(COBRA), is powerful and quick, but only allows analysis at sites recognized by restriction enzymes and 
can be confounded by polymorphisms in the DNA sequence. In contrast, bisulfite sequencing allows 
identification of the methylation status of each CpG site in the bisulfite-modified PCR product and also 
allows detection of most polymorphisms, although cytosine to thymine transitions in the genomic 
sequence will be undetected (Grunau et al., 2001).  
 
Figure 1.2.   The bisulfite conversion reaction.  A) Bisulfite treatment of an unmethylated cytosine 
converts it to uracil, which is replaced by thymine during PCR.  B) The bisulfite reaction proceeds much 
more slowly on methylated cytosines. 
 
The preceding DNA methylation study methods are relatively labor-intensive and not amenable to high-
throughput efforts, but recently several new methods of analyzing DNA methylation have been 
developed.  These include immunoprecipitation of methylated DNA using antibodies against 5-
methylcytosine (ME-DIP) and reduced representation bisulfite sequencing (RRBS), both of which are 
useful for studying DNA methylation on a genomic scale (Suzuki and Bird, 2008; Meissner et al., 2005). 
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Peg3 Imprinted Domain 
The PEG3 protein contains a SCAN box followed by twelve zinc fingers, suggesting that it may 
function as a transcription factor (Li et al., 1999).  Peg3 knockout mice show a phenotype with several 
effects including alterations in maternal behavior, smaller pup size, and higher body fat percentage.  Peg3 
has also been linked to the p53 and apoptosis pathways since it promotes Bax translocation to the cytosol 
(Deng and Wu, 2000).  Recent studies have found that human PEG3 expression is often absent in several 
types of cancers, and DNA hypermethylation on the promoter region appears to be a prime cause for this 
loss of PEG3 expression (Maegawa et al., 2001).  
Peg3 is located within a cluster of imprinted genes that is well conserved evolutionarily-it is found 
in the mouse (proximal chr 7), cow (chr 18), and human (chr 19), as well as in all other mammals.  In the 
mouse, this 500-kb genomic region contains 6 additional imprinted genes, including Usp29/Mim1 (Mer-
repeat containing imprinted transcript 1), Zim1 (Zinc finger gene imprinted 1), Zim2, Zim3, Zfp264 (Zinc 
finger protein gene 264), and APeg3 (Antisense to Paternally expressed gene 3) (Kim and Stubbs, 2005).  
Several members of this domain are also imprinted in human and cow (Kim et al., 2007).  Other studies 
suggest that the epigenetic abnormalities of this domain may be associated with other human diseases 
(Van den Veyver et al., 2001).  Despite this close linkage to human diseases, this domain has not been 
systematically studied so far in humans and other mammals.  
In chapter two, we describe a survey of the DNA methylation status of the Peg3 imprinted 
domain.  This region has been studied in the adult mouse, and selected genes have been studied in the 
human, but we have performed the most comprehensive analysis of DNA methylation in this domain.  We 
analyzed 750 kb of sequence surrounding Peg3 in the mouse, cow, and human genomes for the possible 
presence of CpG islands as well as other characteristics.  To provide a reference for this analysis, we also 
analyzed a 2 Mb region of sequence containing a cluster of non-imprinted genes for the same 
characteristics as above.  Imprinted domains commonly show different patterns of sequence structure than 
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nonimprinted regions of the genome, e.g. SINEs (short interspersed nuclear elements) are depleted and 
LINEs (long interspersed nuclear elements) are enriched in these regions.  We hypothesize that the Peg3 
domain will show some unique sequence characteristics, especially in the distribution of repetitive 
sequence and CpG islands.  Finally, we analyzed the methylation status of DNA obtained from the mouse 
(germline, early development, placenta, and adult tissues), adult cow, and human (both normal and tumor 
tissues).  We expect that the methylation status of the Peg3-CpG island will be well conserved among all 
of the species studied, but that the surrounding CpG islands may show some differences.   
In chapter three, we describe a transcript antisense to ZIM2 (called ZIM2as) in the great apes.  
This transcript spans the region from the first intron of ZNF835 to the fourth from last intron of ZIM2 and 
is expressed in human brain and testis.  This region is the site of a cluster of olfactory receptor genes in all 
the non-primate mammals for which we could obtain genome sequences, including the mouse, cow, and 
dog.  However, the primates have lost this cluster of genes and ZIM2as is present in three great ape 
genomes.  We analyzed expression patterns of ZIM2as and surrounding genes in the human.  We also 
tested the DNA methylation status of several CpG islands surrounding ZIM2as in three different primates: 
rhesus macaque, chimpanzee, and human.  Since olfactory gene clusters elsewhere in the genome act as 
boundaries between differently regulated domains, the cluster present at the 5’ side of the Peg3 imprinted 
domain may function to limit the spread of imprinting.  Long noncoding RNAs in imprinted domains 
often function to maintain imprinting of the surrounding genes and disruption of these transcripts causes 
biallelic expression of the surrounding genes.  Thus, the genomes with (human and chimpanzee) and 
without (rhesus) ZIM2as may differ in terms of the DNA methylation status of the CpG islands near this 
transcript, which could affect expression of the associated genes.   
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Introduction 
The majority of autosomal genes are expressed equally from two parental alleles.  However, in fewer than 
200 mammalian genes, transcription from one allele is epigenetically repressed based on its parent of 
origin due to a process called genomic imprinting (Wagschal and Feil, 2006).  Genomic imprinting is 
found only in marsupials and placental mammals that utilize a unique reproductive strategy in which 
young offspring develop inside females’ wombs.  Most imprinted genes are also involved in controlling 
fetal growth rates and nurturing behaviors (Tilghman, 1999).  The proper dosage of imprinted genes is 
very critical for the survival of these mammals, and abnormal dosages quite often manifest as genetic 
diseases in humans.  The imprinting-related diseases include Beckwith-Wiedemann, Prader/Willi, 
Angelman, and Silver-Russell syndromes as well as autistic spectrum disorders (Ferguson-Smith et al., 
2004; Ideraabdullah et al., 2008).  In addition, several imprinted genes are involved in many types of 
cancers (Jirtle and Skinner, 2007).  Thus, genomic imprinting is regarded as a gene dosage control 
mechanism for this subset of genes critical for mammalian-specific reproductive scheme (John and 
Surani, 2000). 
The promoter regions of imprinted genes are usually associated with CpG-rich regions, termed 
CpG islands.  Some of these CpG islands are differentially methylated in an allele-specific manner, and 
thus called Differentially Methylated Regions (DMRs).  Besides monoallelic expression, the allele-
specific methylation pattern of these CpG islands is another molecular signature that is used to define 
imprinted genes (Ferguson-Smith et al., 2004).  Some of these DMRs also inherit their methylation as a 
gametic signal from the previous generations, and these DMRs play critical roles for maintaining the 
imprinting and transcription of a given domain (Edwards and Ferguson-Smith, 2007).  Abnormal 
methylation levels of these DMRs, either hyper or hypomethylation, are also often associated with many 
types of human diseases as ‘epimutations’ (Hatchwell and Greally, 2007). 
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An evolutionarily conserved imprinted region, the PEG3 domain, is found on human chromosome 
19q13.4/proximal mouse chromosome 7/cow chromosome 18.  In the mouse, this 500-kb genomic region 
contains 6 additional imprinted genes, including Usp29/Mim1 (Mer-repeat containing imprinted transcript 
1), Zim1 (Zinc finger gene imprinted 1), Zim2, Zim3, Zfp264 (Zinc finger protein gene 264), and APeg3 
(Antisense  to Paternally expressed gene 3) (Kim and Stubbs, 2005).  Several members of this domain are 
also imprinted in human and cow (Kim et al., 2007).  According to recent studies, human PEG3 
expression is often missing in several types of cancers and DNA hypermethylation on the promoter region 
appears to be a prime cause for this loss of PEG3 expression (Maegawa et al., 2001).  Other studies 
suggest that the epigenetic abnormalities of this domain may be associated with other human diseases 
(Van den Veyver et al., 2001).  Despite this close linkage to human diseases, this domain has not been 
systematically studied so far in humans and other mammals.  Thus, the current study sought to analyze the 
genome sequence and DNA methylation status of this evolutionarily conserved imprinted domain.  This 
study revealed that the PEG3 domain of humans and mice contains at least two DMRs, but contains only 
one DMR in cows.  In addition, the methylation status of the two human DMRs is often affected in the 
ovary and breast tumor DNA.  
Results  
Characterization of the CpG Islands Located in the PEG3 Domain 
The overall organization of the 500-kb genomic region of the PEG3 domain is well conserved 
among mammals, but the neighboring regions show large-scale genomic changes, such as the loss of an 
Olfactory Receptor (OLFR) cluster as well as a Vomeronasal Organ Receptor (VNO) cluster in the human 
genome (Fig. 2.1). Since the exact boundaries of this imprinted domain are unknown, we analyzed the 
750 kb region surrounding PEG3 from mouse chromosome 7, cow chromosome 18, and human 
chromosome 19.  We identified 50, 34, and 19 CpG islands in the mouse, cow, and human PEG3 regions, 
respectively (Table 2.1). A 2 Mb nonimprinted region that is syntenic between human, mouse, and cow 
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Figure 2.1. Organization of the PEG3 genomic region. 
Outline of the 750 kb genomic region surrounding PEG3 in the mouse, cow, and human.  Directions of 
arrows indicate the direction of transcription.  Maternally expressed genes are indicated by bold red text; 
paternally expressed genes are indicated by underlined blue text.  The positions of the olfactory receptor 
gene cluster (OLFR) and the vomeronasal gene cluster (VNO) are indicated by boxes.  Dotted yellow 
lines indicate the approximate regions in the mouse and cow genomes that contain the OLFR and VNO 
clusters as well as the approximate region from which these clusters were lost from the human genome. 
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Table 2.1.  Analysis of CpG islands and repeat content in the PEG3 imprinted region. 
 Mouse Cow Human 
 Peg3 
Region 
Control 
Region 
Peg3 
Region 
Control 
Region 
Peg3 
Region 
Control 
Region 
Sequence size 750 kb 2 Mb 750 kb 2 Mb 750 kb 2 Mb 
GC content 43.66% 47.31% 47.85% 39.86% 44.36% 40.86% 
CpG islands 36 (15)* 41 34 (13) 16 19 (9) 26 
Tandem Repeats in 
CpG islands 
9 (3.75) 10 1 (0.75) 2 10 (0) 0 
Tandem Repeats in 
entire region 
173 (104) 279 223 (129) 343 49 (31.75) 85 
Total masked bases 19.79% 31.46% 35.49% 49.42% 58.05% 55.78% 
Total interspersed 
repeats 
14.13% 28.89% 34.36% 48.39% 55.68% 54.53% 
SINEs 3.04% 10.93% 15.34% 15.17% 21.57% 14.45 
LINEs 6.75% 7.89% 14.60% 28.32% 18.87% 25.50% 
LTR  3.70% 8.99% 2.65% 3.78% 10.67% 11.71% 
*number in parentheses indicates expected number, based on number in control region 
 
and contains a cluster of zinc finger genes was used as a basis for analysis of the sequence characteristics  
of this region.  The PEG3 region and its associated CpG islands show several interesting differences when  
compared to the reference region.  First, although the overall GC content of the PEG3 region and the 
reference region are similar, the PEG3 region contains more CpG islands than expected.  Second, both the 
PEG3 region and the CpG islands contain more tandem repeats than expected.  These tandem repeats 
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were detected using the Tandem Repeat Finder program, and consist of simple sequence repeats ranging 
in size from approximately 15 bp to several hundred bp.  Third, the repeat content of the PEG3 domain 
deviates greatly from the reference region.  Lower levels of SINEs, LINEs, and LTRs were found in the 
mouse, and reduced levels of LINEs and LTRs were found in both the human and cow sequences.  
Fourth, the CpG islands in this region are mainly found in regions near genes: 50% (mouse), 58% (cow), 
and 84% (human) of the CpG islands are within 10 kb of an annotated gene.  In addition, 60% (mouse), 
45% (cow), and 63% (human) of the above CpG islands overlap at least one exon.  Although most of the 
CpG islands are not conserved among the three species in terms of sequence and position, one CpG island 
surrounding the first exon of PEG3 appears to be well conserved.  
DNA Methylation Analysis of the CpG Islands from the Mouse Peg3 Domain  
We analyzed the methylation status of the computationally predicted CpG islands along with several other 
regions associated with genes in the Peg3 imprinted domain using genomic DNA from the mouse, cow, 
and human.  Briefly, this genomic DNA was treated via bisulfite conversion, and then the bisulfite-
converted DNA was amplified using PCR.  The resulting bisulfite PCR products were analyzed by 
COBRA (COmbined Bisulfite Restriction Analysis) (Xiong and Laird, 1997) and/or subcloning and 
sequencing (Fig. 2.2A).  
Within the mouse Peg3 domain, we targeted four CpG islands (Zim1, Zim2, Zim3, and Peg3) 
using genomic DNA isolated from various Mus musculus samples as well as from the livers of F1 and F2 
offspring of interspecific crosses between M. musculus and M. spretus.  The use of DNA from both F1 
and F2 animals allowed us to exclude the possibility that the genetic background of the mice affected our 
methylation analysis.  In addition, since the F1 and F2 samples are from mice of different ages (three 
months and two weeks old, respectively), we are able to determine if age has an effect on the methylation 
status of the analyzed regions.  Analysis of DNA from placenta, germ cells, blastocyst stage embryos, ES 
cells, and adult mice gave us a developmental stage-specific view of the methylation status of this 
domain.  Sequence polymorphisms between the two parental species were first identified within the 
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Figure 2.2A. Bisulfite sequencing and COBRA analyses of selected CpG islands in the mouse Peg3 
domain Mouse genomic DNA was obtained from Mus musculus sperm, oocytes, blastocysts, embryonic 
stem cells, placenta, and from the liver tissues of the F1 (3 months old) and F2 (2 weeks old) offspring of 
interspecific crossing of M. musculus and M. spretus.    
A) COBRA and bisulfite sequencing analysis. The gene associated with each PCR product is shown to the 
left of the figure.   Each DNA sample was treated with sodium bisulfite and used in the PCR reaction.  
Next, each PCR product was cloned and sequenced and/or analyzed by the COBRA analysis in which 
each PCR product was digested with the enzyme shown to the right of each picture to assess the 
methylation level of the region (*: the Peg3-CpG island was digested with BstUI in the sperm DNA 
sample).  Total digestion by this enzyme indicates methylation of the region and a lack of digestion 
indicates the absence of methylation in the region.  For each COBRA panel, column U contains DNA that 
was not exposed to the selected restriction enzyme, and column C contains DNA that was exposed to the 
restriction enzyme.  The arrow labelled U indicates the position of undigested, unmethylated DNA, and 
the arrow labelled M indicates the position of digested, methylated DNA.  Repeated analyses (at least 
three times) yielded similar results, so a representative picture is shown for each COBRA.  For the 
bisulfite sequencing results, each row represents a different clone, and each column represents a different 
CpG site.  The name of the gene associated with each CpG island is indicated above each set of results.  
Filled circles indicate methylated cytosines and open circles indicate unmethylated cytosines.    
 
studied CpG regions, and later used to differentiate the parental alleles in the F1 and F2 samples.  The 
Zim1-CpG island was not digested by the enzyme HhaI in any of the tested samples, showing a lack of 
methylation in the region at all of these stages, although we were unsuccessful in obtaining data on this 
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region in the blastocyst stage embryo.  Bisulfite sequence analysis of this region confirmed this result.  As 
demonstrated in earlier studies (Li et al., 2000), the CpG island near the promoter of Peg3 displayed a 
maternal allele-specific methylation pattern based on results from both COBRA and bisulfite sequencing.  
The Peg3-CpG island was almost completely methylated in oocyte DNA and lacked methylation in the 
sperm DNA, as expected for a maternally methylated DMR, while ES cell, placenta, and both F1 and F2 
adult tissues derived DNA showed the expected DMR pattern.  At the Zim2-CpG island, a small amount 
of PCR product was digested after incubation with the enzyme TaqI in the sperm-derived DNA.  This 
pattern could either be a result of somatic contamination of the sperm-derived DNA or could indicate that 
there are low levels of methylation in sperm DNA.  In contrast, the placenta, ES cell, F1, and F2 samples 
all show digestion of approximately 50% of the PCR products.  This pattern indicates about half of these 
PCR products are methylated.  Bisulfite sequencing of the PCR products confirmed this result, but the 
methylation was not allele-specific.  The first four CpG sites were all methylated in most clones, while the 
next four CpG sites were unmethylated in most clones, and the ninth CpG site (which is part of the TaqI 
enzyme site used for COBRA) was methylated in approximately half of the clones.  The PCR product 
from the Zim3-CpG island showed approximately 50% digestion with the enzyme BstUI in DNA derived 
from blastocyst, placenta, F1, and F2 mice, indicating that half of the PCR products were methylated (Fig. 
2.2A).  Sequencing revealed that the unmethylated DNA was mostly derived from the maternal allele 
(Fig. 2.2A).  This is consistent with the maternal allele-specific expression of Zim3 (Kim et al., 2001).  
However, the Zim3-CpG island is unmethylated in sperm DNA and ES cell DNA, suggesting that the 
methylation on this CpG island is not inherited as a gametic signal, but that allele-specific methylation at 
this CpG island may be a somatic signal established during early development of the mouse.  
Overall, the Zim3-CpG island appears to be the second DMR (Differentially Methylated Region) 
discovered in the mouse Peg3 domain.  In addition, we show that the CpG island near Zim1 is 
unmethylated, based on the lack of digestion of bisulfite PCR products by HhaI and analysis of the 
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sequence of individual Zim1 PCR products.  The Zim2-CpG island showed a pattern of DNA methylation 
that is not allele-specific, but rather stage- or tissue-specific (Fig. 2.2B).  
DNA Methylation Analysis of the CpG Islands from the Cow Peg3 Domain  
We performed a similar series of analyses using DNA prepared from the liver of F1 hybrid offspring of 
Bos taurus and B. indicus.  We analyzed CpG islands associated with Peg3, Usp29, Ast1, Zim2, and Zim3.  
The COBRA results from the CpG islands near Zim2 and Zim3 showed digestion of nearly all of the PCR 
products, and bisulfite sequencing confirmed that most of the CpG sites are methylated.  The CpG island 
associated with Zim2 showed a similar pattern of total digestion indicating complete methylation.  We 
also analyzed the CpG island located close to the promoter of cow Usp29 since this has been shown to be 
an imprinted gene with paternal allele specific expression (Kim et al., 2007).   
 
Figure 2.2B.  Summary of methylation at different developmental time points in each of the four 
loci tested.  Open circles indicate unmethylated regions, completely filled black circles indicate 
methylated regions, half-filled black regions indicate probable DMRs, and gray circles indicate time 
points for which there is no data available.   
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However, the results from the DNA methylation analyses revealed that the CpG island near this gene is 
almost completely methylated in the cow (Fig. 2.3).  It is important to note that although cow Usp29 is 
imprinted, this gene has lost its ORF (Open Reading Frame) capability in recent evolutionary time, 
suggesting some changes in the bovine lineage (Kim et al., 2007).  Thus, the hypermethylation of the 
Usp29-CpG island of cow might be related to the loss of its ORF during evolution.  In contrast, lack of 
digestion by HhaI shows that the CpG island near Ast1 is not methylated at all.   As predicted, the CpG 
island close to the Peg3 promoter is methylated in an allele-specific manner (Fig. 2.3).   
  
Figure 2.3. Bisulfite sequencing and COBRA analyses of the cow Peg3 domain 
Cow DNA was obtained from the liver of offspring of interspecific crossing of Bos taurus and Bos 
indicus.  The gene associated with each PCR product is shown to the left of the figure.   Each DNA 
sample was treated with sodium bisulfite, used in the PCR reaction, and then cloned and sequenced and/or 
analyzed by the COBRA analysis.  For each COBRA panel, column U contains DNA that was not 
exposed to the selected restriction enzyme, and column C contains DNA that was exposed to the 
restriction enzyme listed on the right side.  On the right side of the COBRA panel, the arrow labelled U 
indicates the position of undigested, unmethylated DNA, and the arrow labelled M indicates the position 
of digested, methylated DNA. Repeated analyses (at least three times) yielded similar results, and a 
representative picture is shown for each COBRA.  For the bisulfite sequencing results, each row 
represents a different clone, and each column shows a different CpG site.  Filled circles indicate 
methylated cytosines and open circles indicate unmethylated cytosines.    
  
Bisulfite sequencing results further confirmed maternal allele-specific methylation at this CpG island 
(Fig. 2.3), consistent with the paternal allele-specific expression of cow Peg3.  In summary, this survey 
indicated that the Peg3-CpG island is the only DMR known at this time to exist in the cow Peg3 region. 
DNA Methylation Analysis of the CpG Islands from the Human PEG3 Domain   
We also performed a series of DNA methylation analyses of the CpG islands identified from the  
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human PEG3 domain (Fig. 2.4).  These include the CpG islands located close to ZNF71 (Zinc finger 
protein71), ZNF835 (Zinc finger protein 835), PEG3, USP29, DUXA (double homeobox A), and ZNF264 
(Zinc finger protein 264).  In addition, we analyzed the promoter region of ZIM3 to allow for comparison 
of the methylation status of this region between the cow, mouse and human, and also a CpG island that 
was predicted by MethPrimer to exist in the first intron of DUXA (DUXA-5/6).  We used human genomic 
DNA isolated from the brain, testis, lung and liver of 4 normal individuals.  Representative results from 
the adult brain and testis of different individuals are shown in Fig. 2.4.  The methylation status of the CpG 
islands in the human PEG3 domain can be summarized as follows.  The PCR products derived from the 
CpG islands of ZNF71, ZIM3, ZNF264, and DUXA (DUXA-3/4) were not digested by their respective 
restriction enzymes, indicating that these CpG islands were unmethylated in the tested DNA from adult 
brain, testis, liver and lung.   
In contrast, the PCR products from the CpG island in the first intron of DUXA (DUXA-5/6) 
showed the opposite pattern in the COBRA analysis: the majority of this region was digested, indicating 
methylation.  Digestion of the ZNF835 PCR product by HpyCH4IV revealed a tissue-specific methylation 
pattern: less DNA was digested in the sample derived from testis, indicating hypomethylation compared 
to the brain sample.   
Finally, the CpG islands of PEG3 and USP29 showed a digestion pattern characteristic of a differentially 
methylated region: only half of the PCR products were digested while the other half remained undigested 
(Fig. 2.4).  We could not determine allele-specific methylation in either locus since the tested regions of 
both PEG3 and USP29-CpG islands lack sequence polymorphisms.  However, the results from bisulfite 
sequencing of the PEG3-CpG island clearly indicated that half of the clones were methylated while the 
other half were unmethylated, the typical pattern of a DMR (Fig. 2.5).  In contrast, the bisulfite 
sequencing results of the USP29-CpG island showed a less clear pattern than the PEG3-CpG island.  
About half of the clones from testis DNA (4 out of 10 clones, 26.3% of the CpGs) showed methylation 
whereas a much greater number of the clones from brain DNA showed methylation but with high levels 
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of mosaicism (54.5% of the CpGs were methylated).  It is important note that human USP29 is expressed 
only in testis (Kim et al., 2000).  Thus, it is possible that the observed higher levels of methylation at 
brain might reflect the transcriptional activity of human USP29, but this remains to be tested in the near 
future. 
 
Figure 2.4. COBRA analysis of the CpG islands located in the human PEG3 imprinted region.  
Human DNA was derived from normal brain, normal testis, breast tumor, and ovary tumor.  Each DNA 
was converted using sodium bisulfite and used in the PCR product.  Each PCR product was incubated 
with the enzyme indicated to the right of the figure.  Repeated analyses (at least three times) yielded 
similar results, so a representative picture is shown for each COBRA.  The gene associated with each 
PCR product is shown to the left of the figure.   Each lane contains DNA that was incubated with the 
appropriate restriction enzyme.  The arrow labelled U indicates the position of undigested, unmethylated 
DNA, and the arrow labelled M indicates the position of digested, methylated DNA. 
 
Since several independent reports previously indicated the hypermethylation of human PEG3-DMR in 
cancers (Maegawa et al., 2001), we also performed a similar series of DNA methylation analyses using 4 
representative cancer DNAs of different tissue origin, including ovary, breast, lung and liver.  According 
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to the results from this survey (Fig. 2.4), the two DMRs of the human PEG3 domain were affected in two 
cancer types, ovary and breast, but not in lung and liver (Appendix A).   
In the case of the PEG3-DMR, half of the PCR products from breast cancer DNA were digested by 
HpyCH4IV, which is similar to the pattern observed from normal brain and testis DNA.  However, the 
same analysis revealed that more than half of the PCR products from ovarian cancer DNA were digested 
by HpyCH4IV, suggesting hypermethylation in this cancer DNA (Fig. 2.4, lanes marked by ♦).  About 
80% of the ovarian cancer DNA showed methylation at the PEG3-DMR although three other samples 
show much lower levels of methylation.  This result was further confirmed through sequencing the PCR 
products as shown in Fig. 2.5.  In addition, the previously undiscovered USP29-DMR showed a similar 
pattern-the majority of the PCR products from both breast and ovarian cancer DNA were digested by 
TaqI, suggesting that this CpG island is also hypermethylated in these two types of cancer DNA.  Our 
sequencing analyses indeed confirmed the hypermethylation of USP29-DMR in breast and ovarian cancer 
DNAs (Fig. 2.5).  The hypermethylation levels in the ovarian cancer DNA appears to be much greater 
(81.8% of CpGs are methylated) than those in the breast cancer DNA (65.5% of CpGs are methylated).  
Also, it is interesting to note that the methylation pattern at the breast cancer DNA is somewhat mosaic, 
which is similar to the pattern seen in normal brain DNA but with much more methylation.  For this series 
of analyses, we have also included the human H19-DMR as a control.  As shown in Fig. 2.4, this region 
showed a DMR pattern in the normal DNA as well as two types of cancer DNA.  This also suggests that 
the observed DNA hypermethylation may be specific to the two DMRs of the human PEG3 domain.  In 
sum, the data presented above is consistent with the previous observations revealing the hypermethylation 
of human PEG3 in cancer (Maegawa et al., 2001), and further indicates that this hypermethylation 
probably occurs on the DMRs of both PEG3 and USP29 in cancer DNA. 
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Figure 2.5. Bisulfite sequencing of the CpG islands located in the human USP29 and PEG3 
promoter regions.   
Results obtained from analysis of normal brain and testis derived DNA are shown along with breast and 
ovary tumor-derived DNA.  Each row indicates a different clone, and each column indicates a different 
CpG site.  Filled circles indicate methylated cytosine and open circles indicate unmethylated cytosine.  
The analyzed CpG islands are indicated with the name of the gene with which they are associated. 
 
Discussion  
In this study, we surveyed methylation status of the CpG islands of the PEG3 imprinted domain in the 
mouse, cow, and human genomes.  This survey led to the discovery of two previously unreported 
differentially methylated regions: mouse Zim3 and human USP29.  In addition, we examined the 
methylation status of the CpG islands in this region using human tumor derived DNA.  The CpG islands 
near PEG3 and USP29 both showed hypermethylation in DNA derived from breast and ovarian tumors.  
 We performed a comprehensive analysis of the sequence in the 750 kb region containing the 
PEG3 imprinted domain.  This analysis showed that the sequence structure in this region was different 
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from a non-imprinted region containing similar types of genes (Table 2.1).  Both tandem repeats and CpG 
islands were over-represented in both the entire sequence and the CpG island sequence of the PEG3 
region.  Tandem repeats have been reported to be associated with imprinted genes, and may play a role in 
setting up DNA methylation for the CpG islands of imprinted genes during gametogenesis (Hutter et al., 
2006).  It is well known that tandem repeat sequences can attract DNA methylation although it is still 
unclear how only one allele of tandem repeats become methylated in the case of imprinted genes, such as 
the DMRs of imprinted genes.  At the same time, the tandem repeats may also play a role in the genesis 
and maintenance of CpG islands during evolution.  Since methylated cytosines are prone to mutation, 
CpG islands (which contain high numbers of cytosines) must be protected from this mutation by some 
mechanism.  Tandem duplication of CpG islands, which would increase the overall size of the island, 
could be one way to prevent attrition of cytosines.  These two conflicting needs might have contributed to 
increasing the number of tandem repeats in the CpG islands of mammalian imprinted genes.  
 In the mouse, we analyzed four CpG islands associated with Zim1, Peg3, Zim3, and Zim2, 
respectively.  We assessed methylation status of each CpG island in DNA obtained from sperm, 
blastocyst, embryonic stem cell (ES cell), placenta, and in somatic tissue from mice of two different ages 
(two weeks and three months) (Fig. 2.2).  Methylation status of other loci is known to show differences at 
different stages of development, and also with age, but a broad survey such as this has not been 
previously performed in the PEG3 imprinted region.  The Zim2- and Zim3-CpG islands showed different 
patterns between blastocysts and ES cells, which are at a similar stage of development: Zim2 was 
unmethylated in the blastocyst and showed a DMR-type digestion pattern in the COBRA results from the 
ES cell, and Zim3 had a DMR pattern in the blastocyst and was unmethylated in the ES cell.  While the 
Peg3-DMR has been shown to be stable in ES cells, other regions have not, so this change in methylation 
at these regions can probably be attributed to the effects of ES cell culture (Chang et al., 2009).  Peg3, 
Zim2, and Zim3 all show approximately 50% digestion of DNA derived from the placenta.  This may 
indicate that the methylation pattern of these regions in the placenta is similar to that found in the adult 
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somatic tissue, which could indicate that these genes are regulated similarly in the placenta and somatic 
tissues, although it is also possible that this pattern is due to the fact that the placenta is derived from both 
maternal and fetal cells.   The current study identified two additional DMRs, Zim3-DMR in the mouse 
and USP29-DMR in the human (Fig. 2.6).   
 
Figure 2.6. Summary of the methylation status of CpG islands in the PEG3 region 
Outline of the 750 kb genomic region surrounding PEG3 in the mouse, cow, and human.  Directions of 
arrows indicate the direction of transcription.  Maternally expressed genes are indicated by bold red text; 
paternally expressed genes are indicated by underlined blue text.  The boxes show the approximate 
position of the olfactory (OLFR) and vomeronasal (VNO) gene clusters.  Dotted yellow lines indicate the 
approximate regions in the mouse and cow genomes that contain the OLFR and VNO clusters as well as 
the approximate region from which these clusters were lost from the human genome.  Below each 
chromosome, black boxes indicate methylated regions, empty boxes indicate unmethylated regions, half-
filled boxes indicate differentially methylated regions, and grey boxes containing the letter T indicate 
potential tissue-specific methylation patterns. 
 
However, the DMR status of these CpG islands appears to be lineage-specific.  First, although the 
Zim3-CpG island is methylated in an allele-specific manner in the mouse, both alleles of the human 
ZIM3-CpG island are unmethylated, and both alleles of the cow Zim3-CpG island are methylated (Fig. 
2.6).  Second, the human USP29-CpG island appears to be a DMR in a tissue-specific manner in the 
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testis, but the homologous region in cow showed hypermethylation, indicating that both alleles may be 
methylated.  These differences might be an indication of the presence of some species-specific changes in 
the imprinting status of the surrounding genes.  In this regard, it is interesting to point out the presence of 
a genomic rearrangement in the rodent lineage: the mouse genome does not contain the Duxa gene 
between Zim3 and Zfp264 although two other lineages, human and cow, have this gene, suggesting that a 
lineage-specific deletion event occurred during rodent evolution.  Also, the mouse genome contains a very 
long (over 300 kb) Usp29 transcript while this long transcript has been truncated in the human and cow 
lineages (Fig. 2.6).  This transcript could be one of the mechanisms that maintains the imprinted status of 
the surrounding genes, similar to the functions of Air and Kcnq1ot1 in their respective imprinted domains 
(Ideraabdullah et al., 2008).  Once we obtain the imprinting status of human and cow ZIM3, it is possible 
that the relationship between this genomic deletion and the imprinting status of the surrounding genes will 
be clarified.  
 PEG3 expression is silenced in various tumor types, including gliomas, choriocarcinomas, and 
ovarian tumors (Maegawa et al., 2001; Van den Veyver et al., 2001).  This silencing of human PEG3 was 
found to be a result of DNA methylation (Murphy et al., 2001).  Our results also confirm the 
hypermethylation of cytosines at the PEG3-DMR in ovarian tumor-derived DNA (Fig. 2.4& 2.5).  
Although some regions show tissue-specific methylation patterns, the PEG3-DMR is methylated on the 
maternal allele only over a range of normal tissues.  In each normal tissue, we expect to see a pattern in 
which approximately half of the bisulfite clones are unmethylated and half are methylated.  Since this 
CpG pattern has such a consistent methylation pattern, any deviation from this in abnormal tissues is 
probably meaningful.  This study only analyzed a limited number of samples, but other studies of human 
cancers have shown hypermethylation of this region and reduced PEG3 expression (Maegawa et al., 
2001; Feng et al., 2008).  Our study showing hypermethylation in the PEG3-CpG island in ovarian cancer 
DNA adds to the evidence supporting the hypothesis that PEG3 functions as a tumor suppressor.  We also 
found an increase in the DNA methylation level at the USP29-DMR in breast and ovarian tumor DNA.  
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Since this CpG island tends to show mosaicism in its DNA methylation pattern, it is unclear whether the 
observed increase in the DNA methylation levels in the two types of cancer DNA truly represents 
abnormal DNA methylation or is simply a tissue-specific methylation pattern.  However, it is relevant to 
note that human USP29 was previously discovered through a screen of a tumor-derived expression library 
(Tureci et al., 2002).  Although human USP29 is known to be expressed only in the testis, the expression 
of this gene has been seen in several types of cancers.  This further suggests a potential role of human 
USP29 in human cancer.  Also, it is well known that several genes in a given imprinted domain tend to be 
co-regulated in terms of its expression and epigenetic modifications.  Thus, it is likely that the observed 
DNA methylation changes in the USP29-DMR along with PEG3-DMR might reflect together the 
abnormal status of DNA methylation in the two tissues tested in this study.  This could suggest a link 
between abnormal expression of USP29 and PEG3 in human cancers. 
Methods 
CpG Island Prediction and Sequence Analysis 
A Perl script was used to analyze the genomic sequences surrounding the PEG3 imprinted domain (Chr 
19:  61750000-62500000, 750 kb for human; Chr. 7: 6293901-7043900, 750 kb for mouse; Chr. 18: 
6398699-6473700, 750 kb for cow) and a nonimprinted region containing similar types of genes that was 
used to provide a basis for comparison for sequence analysis (Chr 1: 244543476-246543476 for human; 
Chr. 11: 58303940-60303939 for mouse; Chr. 7: 38923539-40923539 for cow).  For the cow and human 
sequences, this Perl script was set to recognize a sequence as a CpG island only if three conditions were 
met: length greater than 500 bp, C+G content greater than 55%, and observed/expected CpG ratio at least 
0.65 (Takai and Jones, 2002).  An initial CpG island prediction using these criteria resulted in very few 
predicted islands in mice, so the minimum length parameter was reduced to 200 bp for this species only.  
To test evolutionary conservation, the sequence of each CpG island was analyzed using BLAST (Altschul 
et al., 1990) and the ECR browser of the dcode website (http://www.dcode.org/) (Ovcharenko et al., 
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2004).  The CpG islands predicted by this program were also analyzed for the presence of repetitive 
elements using RepeatMasker and Tandem Repeat Finder (Smit 1996-2004, Benson 1999).  The default 
parameters and appropriate species were used for RepeatMasker, and the parameters for Tandem Repeat 
Finder were adjusted as follows (Hutter et al., 2006): match score 2, mismatch score 5, indel score 7, 
match probability 80, indel probability 10, minscore to report 100, maxperiod 2000.  The sequence of 
each CpG island and related information regarding repeat contents and evolutionary conservation are 
available upon request. 
COBRA (COmbined Bisulfite Restriction Analysis) and Bisulfite Sequencing 
Mouse genomic DNA was isolated from the liver tissues of the F1 (3 months old) and F2 (2 weeks old) 
offspring of interspecific crossing of Mus musculus and M. spretus (Kim et al., 2001).  Mouse placentas 
were isolated from 17 day embryos.  Mouse sperm DNA was isolated from the epididymis of 3 month old 
male mice according to a previously established protocol (Bunch and Saling, 1991).  Briefly, the 
epididymides were incubated in sperm elution buffer (130 mM NaCl, 20 mM Tris, 2 mM EDTA pH 7.4) 
for ten minutes at 37°C.  The epididymides were then removed and the solution was centrifuged for 30 
seconds at 800 rpm.  Then, the sperm were washed twice more with the sperm elution buffer.  The 
isolated sperm were examined under a microscope, and only samples that did not display somatic cell 
contamination were used for the methylation analyses.  The sperm from a single mouse (~105-106 sperm) 
was pooled and subjected to bisulfite conversion.  In preparation for isolation of blastocyst-stage 
embryos, female mice were superovulated (Eppig and Telfer, 1993; Horgan et al., 1994).  First, 5 IU of 
Pregnant Mare Serum (PMS) (Cat. G4877, Sigma) was injected subcutaneously.  Then, the same mice 
were injected with 5 IU of human Chorionic Gonadotropin (hCG) hormone (Cat. C1063, Sigma) 48 hours 
after the PMS injection.  The treated mice were mated with male littermates, and sacrificed 3.5 days later.  
The embryos were flushed from each uterus, and the isolated blastocysts were examined under the 
microscope to assess their developmental stages and purity.  Only embryos at the blastocyst stage were 
used for methylation analysis.  Seven blastocysts were pooled for bisulfite treatment of the DNA.   To 
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isolate oocytes, female mice were superovulated as described above, but the mice were sacrificed 12 
hours after the second injection.  Mature eggs were isolated from the swollen ampulla of the oviducts, 
incubated in hyaluronidase solution (Cat. H3506, Sigma) for several minutes to separate the cumulus 
cells, and subsequently washed three additional times to remove potential somatic tissue contamination.  
DNA isolated from approximately 400 oocytes obtained from ten females (8 weeks old) was pooled and 
used for bisulfite conversion. 
 Cow genomic DNA was also isolated from the liver of the hybrid offspring of interspecific 
crossing of Bos taurus and B. indicus.  These hybrid animals have been previously used to test imprinting 
of several genes in the PEG3 domain (Kim et al., 2001).  Human genomic DNAs derived from normal 
and tumor tissues were obtained from a commercial firm (Biochain).   
 Each DNA (2 μg) was modified with the bisulfite conversion reaction according to the 
manufacturer protocol (EZ DNA methylation kit, Zymo Research).  The converted DNA was eluted with 
15 μl of TE.  Each converted DNA (1 μl) was used as a template for PCR with primers designed using the 
MethPrimer program (Li and Dahiya, 2002).  The PCR amplification was performed using the Maxime 
PCR premix kit (Intron Biotech, South Korea).  Information regarding the primer sequences and detailed 
PCR conditions for each tested region are available in Appendix A.  
The amplified PCR products were analyzed using restriction enzyme digestion (COBRA) (Xiong 
and Laird, 1997).  Each PCR product was analyzed with two sets of restriction enzymes.  First, the 
efficiency of the bisulfite conversion reaction was monitored with a set of enzymes that contain non-CpG 
cytosines in their recognition sites (DdeI, HpaII; data not shown).  Any digestion by these enzymes 
indicates that the conversion reaction was incomplete.  A second set of enzymes that distinguish between 
unmethylated and methylated DNA were chosen to analyze the degree of methylation in each tested 
region.  The recognition site of each of these enzymes contains a CpG site (TaqI, BstUI, HhaI and 
HpyCH4IV) or a TpG site (HphI).  Since methylation inhibits the conversion of cytosines into thymidines 
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during the bisulfite conversion, bisulfite-treated DNA will be digested by the first group of enzymes if the 
DNA is methylated.  The recognition site for HphI is GGTGA(N)8, so it will only digest DNA in which 
the CpG site is unmethylated in vivo.  Each of these restriction digestion reactions was repeated at least 
three times.  
Some of the PCR products amplified from the bisulfite-treated DNA were further analyzed 
through cloning and sequencing.  Each of the selected PCR products was purified using the MEGA-Spin 
agarose gel purification kit (Intron), and then individually cloned into the pGEM-tEasy vector (Promega).  
At least 10 different clones were randomly selected for DNA sequencing for each PCR product.  Due to a 
cloning bias toward methylated fragments in the mouse Zim2 and Zim3 regions, methylated and 
unmethylated fragments were separated using COBRA, gel purified, and the unmethylated fragment was 
ligated into the pGEM-tEasy vector.  The purified plasmid DNA was sequenced using BigDye v3.1 
(Applied Biosystems).  Unincorporated primers and dye terminators were removed via ethanol 
precipitation, and an ABI 3130 XL was used to analyze the results.  To determine methylation status, the 
resulting electropherograms were visually inspected in BioEdit (Hall, 1999).  
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CHAPTER THREE: IDENTIFICATION OF AN ANTISENSE TRANSCRIPT TO 
ZIM2 IN THE PRIMATE LINEAGE* 
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Introduction 
Most autosomal genes are expressed equally from two parental alleles, but up to 200 mammalian genes 
are only transcribed from one allele based on the parent of origin due to a process called genomic 
imprinting (Ideraabdullah et al., 2008).  Genomic imprinting is found only in marsupials and placental 
mammals, organisms that utilize a unique reproductive strategy in which young offspring develop inside 
females’ wombs.  Genomic imprinting is a critical gene dosage control mechanism for a subset of genes 
involved in this strategy (John and Surani, 2000).  Most imprinted genes are involved in controlling fetal 
growth rates and nurturing behaviors (Tilghman, 1999).  Proper dosage of imprinted genes is critical for 
the survival of mammals, and abnormalities in the dosages quite often manifest as genetic diseases in 
humans.  Imprinting-related diseases include Beckwith-Wiedemann, Prader/Willi, Angelman, and Silver-
Russell syndromes as well as autistic spectrum disorders (Ferguson-Smith et al., 2004; Ideraabdullah et 
al., 2008).   
 Although imprinted genes are found only in mammals, their imprinting status of these genes is not 
always conserved among all mammals.  For example, Igf2r (Insulin-like growth factor type-2 receptor) is 
imprinted in the mouse, but is biallelically expressed in the human (Kalscheur et al., 1993).  This domain 
is an example of one common feature of imprinted domains:  the expression of antisense transcripts that 
regulate imprinting (Pauler et al., 2007).  Another common feature of imprinted domains is the presence 
of CpG islands with allele-specific methylation patterns (differentially methylated regions: DMR) 
(Ferguson-Smith et al., 2004).  Some of these DMRs inherit their methylation as a gametic signal from 
the previous generations, and these DMRs play critical roles for maintaining the imprinting and 
transcription of a given domain (Edwards and Ferguson-Smith, 2007).  Abnormal methylation levels of 
these DMRs, either hyper or hypomethylation, are also often associated with many types of human 
diseases as ‘epimutations’ (Hatchwell and Greally, 2007).   
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  An evolutionarily conserved imprinted region, the PEG3 (Paternally expressed gene 3) domain, is 
found on human chromosome 19q13.4/chimpanzee chromosome 19/rhesus macaque chromosome 
19/proximal mouse chromosome 7.  In the mouse, this region contains several imprinted genes including 
Peg3 and Zim2 (Zinc finger imprinted gene 2).  The overall structure of the PEG3 imprinted domain is 
generally well conserved among mammals, but there have been several lineage specific changes in this 
region.  For example, a cluster of olfactory receptor genes that is present in most mammals has been lost 
from the primate lineage (Huang and Kim, 2009).  Since this deletion of olfactory receptor genes is 
adjacent to the PEG3 imprinted domain, we analyzed the effects of this change in terms of sequence 
structure of the region and methylation and expression levels of nearby genes.  This study revealed the 
presence of an antisense transcript to ZIM2, called ZIM2as, in this region of the human, orangutan and 
chimpanzee genomes. 
Results 
Olfactory Receptor Deletion in Primates 
The region between Zfp28 (Zinc finger protein 28) and Zim2 contains a cluster of olfactory receptor genes 
in the cow, dog, mouse, and several other mammals (Fig. 3.1).  However, this location is devoid of 
olfactory receptors in the rhesus macaque, orangutan, chimpanzee, and human.  This deletion was 
accompanied by a loss of approximately 90 kb between the mouse and rhesus macaque regions.  
Comparison of the rhesus, orangutan, chimpanzee, and human sequences revealed the presence of a 
cluster of tandem repeats in this region in the human, orangutan, and chimpanzee genomes only, which 
are responsible for an approximately 70 kb size difference between this region in the rhesus macaque and 
the same region in humans, orangutans and chimpanzees (Fig. 3.2).  Analysis of ESTs suggested the 
possibility of a transcript spanning this region (AI829612.1, DA176232.1, BG707577, AL554662, 
BX365418.2, BM710959, AW850989), and cDNA cloning and sequencing confirmed the identity of the  
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Figure 3.1. Organization of the region between ZFP28 and PEG3 in the mouse, rhesus macaque, 
chimpanzee, and human genomes.   
Since the size of this region is different in each organism, this figure is drawn to the scale indicated in the 
upper right corner.  The location for the sequences shown in this figure are human (hg18)-
chr19:61,742,129-62,050,982; chimpanzee (panTro2)-chr19:62,386,300-62,704,467; and rhesus 
(rheMac2)-chr19:62,502,756-62,749,741.  Arrows show the direction of transcription.  The mouse region 
is shown as a representative of the non-primate mammals that possess a cluster of olfactory receptor genes 
in this region.  The tree is only representative of the relative relationship between these four animals, and 
branch lengths are not to scale.   
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Figure 3.2.  Structure of the ZIM2as transcript and the surrounding sequence. 
Dot plot comparison of the sequence structure of the region between ZNF71 and PEG3 in the rhesus 
macaque and chimpanzee against human.  The locations of the sequences used for this analysis are human 
(hg18)-chr19:61,797,100-62,047,400; chimpanzee (panTro2)-chr19:62,451,000-62,701,000; orangutan 
(ponAbe2)-chr19:58,643,223-58,893,596; and rhesus macaque (rheMac2)-chr19:62,498,300-62,748,400.  
Each identity between the two sequences is plotted as a dot, so the diagonal line seen in each graph shows 
a region of sequence similarity.  The human sequence is on the x axis of each graph.  In the diagrams on 
the right, two CpG islands in the promoter region of ZIM2as are indicated by asterisks (*) and labeled 
with the names of the primers used to analyze methylation in this region.    
A) Rhesus vs. human.  The corresponding rhesus macaque sequence is on the y axis of the dot plot, and 
the diagram on the right shows the structure of the genes in the indicated region of the rhesus genome.  
Exons are indicated by boxes, introns by lines, and arrows indicate the direction of transcription.   
B) Orangutan/chimpanzee vs. human.  Similar results were seen using chimpanzee and orangutan 
sequence, and the chimpanzee sequence is shown on the y axis of the dot plot.  The diagram on the right 
shows the structure of the genes in the studied region in the human, orangutan, and chimpanzee genomes, 
including ZIM2as.   The ZIM2as transcript is 568 bp long, has five exons, and spans over 118 kb of 
genomic region.  The first exon is found within the first intron of ZNF835 and the final exon is found 
within an intron of ZIM2.  Exons are indicated by boxes, introns by lines, and arrows indicate the 
direction of transcription.   
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ZIM2as transcript in the human (Genbank accession No. FJ997633) (Fig. 3.2B).  The exons of ZIM2as 
are also detected in other primates, chimpanzee and orangutan, with 99% and 97% sequence identity, 
respectively.  Furthermore, one orangutan EST (CR629606) was found to be derived from the 5’-end 
portion of ZIM2as.  These results strongly suggest that ZIM2as is evolutionarily conserved in the great 
apes.  
ZIM2as Transcript Formation  
The ZIM2as transcript is composed of five exons and is 568 bp long, but lacks an ORF (Appendix A).  It 
spans over 100 kb between ZNF835 (Zinc finger protein 835) and ZIM2, beginning within the first intron 
of ZNF835 and ending in the fourth from last intron of ZIM2 (Fig. 3.2).  The 5`-end of ZIM2as is located 
in a nuclease accessible site (Boyle et al., 2008) that shows enrichment in histone 3 lysine 4 
dimethylation, a mark associated with transcriptional start sites (Mikkelsen et al., 2007), suggesting that 
the transcription of ZIM2as likely starts at this site.  We performed RT-PCR-based expression analyses 
using primers specific to the ZNF835, ZIM2as, ZIM2, and PEG3 transcripts (Fig. 3.3).  Expression of 
each of these transcripts was assayed using a commercially available panel containing normalized cDNA 
from human brain, heart, kidney, liver, and placenta as well as human testis.  Out of all the tissues studied, 
ZIM2as expression was detected in the brain and testis (Fig. 3.3).  Expression of the ZNF835 transcript 
was detected in all tested tissues, most strongly in the heart.  Both the ZIM2 and PEG3 transcripts were 
expressed in all tissues tested with relatively high levels in brain and placenta.  
DNA Methylation Analysis 
Since long antisense transcripts are often associated with the maintenance of imprinted domains, we 
tested the methylation status of several genes near ZIM2as.  Briefly, genomic DNA was converted using 
the bisulfite method, and analyzed via restriction enzyme digestion (COBRA, Xiong and Laird, 1997) 
and/or cloning and sequencing.  We analyzed the methylation levels of the DNA that were derived from 
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Figure 3.3. Expression analysis of genes in the vicinity of ZIM2as. 
Expression patterns of  ZIM2as and several nearby transcripts, ZNF835, ZIM2, and PEG3 were analyzed 
by RT-PCR.  GAPDH was used as an internal control.  The tissue origin of each cDNA is indicated on the 
top, and the transcript analyzed is indicated on the left.  The two additional lanes shown for the ZIM2as 
transcript represent results from the cDNA used to clone and sequence this transcript.  These two cDNA 
samples are not normalized with respect to the lanes containing results from the commercial cDNA. 
 
human brain and testis, rhesus and chimpanzee fibroblast cell lines.  We first analyzed the two CpG 
islands near the promoter region of ZIM2as.  The one farther from ZIM2as (named ZIM2as-a) was totally 
digested by HpyCH4 IV in chimpanzee, rhesus macaque, and human brain DNA, indicating complete 
methylation (Fig. 3.4A).   
However, only 50% of the PCR product was digested in the human testis.  Bisulfite sequencing 
and SNP analysis of this region showed allele-specific methylation in the testis (Fig. 3.4B, T vs. G).  
However, we are unable to determine the parent-of-origin of the methylated allele.  The CpG island closer 
to ZIM2as (named ZIM2as-b) showed species-specific methylation patterns (Fig. 3.4A): the human 
samples showed no digestion (indicating a lack of methylation), the rhesus macaque sample showed 
complete digestion, but the chimpanzee sample showed approximately 50% digestion after incubation 
with HpyCH4 IV.  Subsequent bisulfite sequencing of the same chimpanzee sample revealed a mosaic  
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Figure 3.4. DNA methylation analysis of ZIM2as 
The methylation status of CpG islands associated with several genes upstream of the ZIM2as transcript 
was assayed by bisulfite conversion of each DNA sample followed by COBRA and/or cloning and 
sequencing.  Each analyzed CpG island is indicated by the name of the associated gene.   
A) COBRA.  The type of DNA sample is indicated above each column, along with (-) for DNA that was 
incubated without enzyme, and (+) for DNA that was incubated with the appropriate enzyme.  The 
enzyme used for each COBRA is indicated to the right of each gel image.  Arrows labeled U and M 
indicate the position of the unmethylated and methylated DNA bands, respectively.  Each reaction was 
performed at least three times, and a representative image is shown.  The bottom portion of the figure 
contains a summary of the COBRA results in which open boxes indicate a lack of methylation, filled 
boxes indicate complete methylation, and half-filled boxed indicate a DMR region.  The regions that 
show different methylation patterns among the human, chimpanzee, and rhesus macaque are indicated by 
diamonds above each lane. 
B) Bisulfite sequencing.  The associated gene is shown above and the type of DNA sample is shown on 
the left.  The T and G on the right of the human testis bisulfite sequencing result indicate the SNP used to 
separate the two alleles.  Each row of the bisulfite sequencing results indicates a different clone, and each 
column is an individual cytosine within a CpG dinucleotide.  Filled circles indicate methylation, and 
empty circles denote a lack of methylation. 
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pattern of methylation, with no clone being entirely methylated (Fig. 3.4B).  In sum, the two CpG islands 
of ZIM2as displayed species-specific variations among primates, but one of these CpG islands (ZIM2as-
a) showed an allele-specific methylation pattern in human testis DNA.   
To investigate the possibility that the ZIM2as transcript formation coincided with the expansion of 
this imprinted region, we also tested methylation status at several upstream genes, including ZNF71 (zinc 
finger gene 71) and ZNF470 (zinc finger gene 470).  The CpG islands associated with each of these genes 
were unmethylated in the human brain and testis as well as in the chimpanzee and rhesus macaque 
fibroblast, based on lack of digestion when incubated with the appropriate restriction enzyme (Fig. 3.4A).  
This indicates an overall similar pattern between different primates.  We also analyzed two CpG islands 
on the downstream side of ZIM2as.  The PEG3-CpG island showed a typical DMR pattern in all three 
species.  The ZIM3 (Zinc finger gene imprinted 3)-CpG island showed a similar pattern of non-digestion 
(unmethylation) between human and chimpanzee.  However, some fraction of the ZIM3-CpG island from 
rhesus was digested, indicating some levels of DNA methylation, which warrants further investigation in 
the near future.   
 In summary, the above data show that an antisense transcript has formed in the region upstream of 
the PEG3 imprinted domain in the human and chimpanzee.  The two CpG islands close to the promoter of 
this primate-specific transcript gene showed species-specific variations in terms of their DNA methylation 
status.  This is in stark contrast to the stable and conserved DNA methylation pattern observed from the 
nearby zinc finger genes.  One of these CpG islands, Zim2as-a, showed allele-specific methylation in the 
human testis, suggesting that ZIM2as is probably imprinted in the human (Fig. 3.4B).   
Discussion 
In this study, we report the formation of a new primate-specific antisense transcript, ZIM2as, in a region 
containing a cluster of olfactory receptor genes in non-primate mammals (Fig. 3.2).  In the human, this 
transcript is expressed in the brain and testis (Fig. 3.3), and a CpG island within its promoter region 
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shows allele-specific methylation in the testis, suggesting that this transcript may be imprinted (Fig. 3.4).  
The presence and possible imprinting of this antisense transcript gene suggest that the PEG3 imprinted 
domain may have expanded in the great apes.   
The overall structure of the PEG3 imprinted domain is generally well conserved among mammals, 
but there have been several lineage specific changes in this region. Figure 3.5 shows these changes in the 
structure of the area covered by ZIM2as and highlights the probable timing of two major events.  First, a 
cluster of olfactory receptor genes that is present in most mammals has been lost from the primate lineage 
(Fig. 3.1).  Second, an antisense transcript to ZIM2, called ZIM2as, is found in the homologous regions of 
the human, chimpanzee and orangutan genomes. These two changes might be related to each other.  
Clusters of olfactory genes have been shown to be involved as insulators between differently regulated 
chromatin domains (Valenzuela and 
 
Figure 3.5.  Primate-specific changes in the PEG3 region 
The tree is only representative of the relative relationship between these four animals, and branch lengths 
are not to scale.  For simplicity, only selected genes are shown in this figure.  The directional arrows show 
the direction of transcription of selected genes in this region, and the boxes show the positions of the 
olfactory receptor (OLFR) and vomeronasal organ receptor (VNO) gene clusters that flank the Peg3 
imprinted domain in the mouse.  The approximate timings of the olfactory receptor cluster deletion and 
Zim2as transcript formation are shown on the tree. 
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Kamakaka, 2006).  This cluster may have originally acted as a boundary to prevent spreading of 
imprinting outside of the PEG3 domain, and its loss might have triggered the formation of an antisense 
transcript gene, ZIM2as, in the primates.  So far, all the primate genomes analyzed lack this olfactory 
cluster.  On the other hand, sequence analysis and EST searches confirmed the presence of ZIM2as only 
in the great apes, but not in the rhesus genome.  This suggests that the loss of the OLFR cluster may 
predate the formation of ZIM2as, and further predicts that the formation of this antisense gene was around 
15 million years ago.  This antisense transcript gene is most likely imprinted in the humans based on the 
allele-specific DNA methylation observed from the human testis sample (Fig. 3.4B).  We also predict that 
this antisense transcript gene is imprinted in other primates based on the patterns observed from similar 
antisense transcripts in other imprinted domains (Ideraabdullah et al., 2008).  In particular, many antisense 
transcripts associated with imprinted domains also begin in intronic regions, e.g Kcnq1ot1 and 91H 
(Ideraabdullah et al., 2008; Bertaux et al., 2008).  Following this pattern, the beginning of ZIM2as is 
located within the first intron of ZNF835.  If it is the case that ZIM2as is imprinted, it will be interesting 
to test if the PEG3 imprinted domain has indeed expanded in the primate lineage.  In particular, it would 
be of great interest to investigate the potential imprinting of several zinc finger genes located in the region 
immediately adjacent to ZIM2as, in particular ZNF835. 
 It is interesting to note that DNA methylation patterns are not conserved between great apes.  The 
methylation status of two CpG islands adjacent to this end of the transcript differs between the 
chimpanzee and human.  The chimpanzee lacks methylation at the first CpG island (Zim2as-a) and has a 
mosaic methylation pattern at the second (Zim2as-b), while in the human ZIM2as-a is a tissue specific 
DMR and ZIM2as-b is completely methylated (Fig. 3.3B).  This result is consistent with previous reports 
that human and chimpanzee methylation often differs (Enard et al., 2004).  Several possibilities could 
account for this result.  First, the chimpanzee DNA was derived from a cell line, and cell lines have been 
reported to show altered methylation patterns (Chang et al., 2009).  However, four other CpG islands 
(ZNF470, ZNF471, PEG3, and ZIM3) showed the same methylation pattern between chimpanzee and 
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human.  Second, Zim2as-a could represent a testis-specific DMR.  Without access to chimpanzee testis 
tissue, we are unable to determine if this is the case.  Finally, the lineage-specific differences in 
methylation could be due to the recent appearance of this transcript.  There has probably not been enough 
evolutionary time for its regulation to undergo selection pressure, so the imprinting status of this 
transcript might not have been fixed due to the very young age of this gene.   
 In conclusion, both the human and chimpanzee genomes have lost a cluster of olfactory receptors 
from the same region in which the ZIM2as transcript has formed, and the ZIM2as promoter region shows 
allele-specific methylation in the human testis.  Although the loss of the olfactory cluster and the 
formation of ZIM2as were not simultaneous, the methylation data and the fact that this transcript is 
antisense to an imprinted gene suggest that ZIM2as may be imprinted.  Since OLFR clusters often 
function as boundary elements, the loss of this OLFR cluster may have allowed the expansion of the 
PEG3 imprinted domain in the primates. 
Methods 
Sequence Analysis 
The sequences covering the 250 kb upstream of PEG3 were obtained from the UCSC genome browser for 
four species: human (hg18-chr19: 61,742,129-62,050,982), chimpanzee (panTro2-chr19: 62,386,300-
62,704,467), orangutan (ponAbe2-chr19:58,643,223-58,893,596), and rhesus macaque (rheMac2-chr19: 
62,502,756-62,749,741).  Pairwise comparisons between human and chimpanzee, human and orangutan, 
and human and macaque were made using PipMaker (Schwartz et al., 2000).  The genomic DNA was 
analyzed with a Perl script to predict the location of CpG islands.  CpG islands were defined as a region 
of sequence at least 500 bp long with greater than 55% C+G content and an observed/expected CpG 
dinucleotide ratio of at least 0.65 (Takai and Jones, 2002).   
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COBRA (COmbined Bisulfite Restriction Analysis) and Bisulfite Sequencing 
Human genomic DNA derived from normal tissues were obtained from a commercial firm (Biochain).   
Chimpanzee (Pan troglodytes) and rhesus macaque (Macaca mulatta) fibroblast genomic DNA were the 
generous gift of Dr. Mark Batzer.  Each DNA (2 μg) was modified with the bisulfite conversion reaction 
according to the manufacturer protocol (EZ DNA methylation kit, Zymo Research).  The converted DNA 
was eluted with 15 μl of TE.  Each converted DNA (1 μl) was used as a template for PCR with primers 
designed using the MethPrimer.  The PCR amplification was performed using the Maxime PCR premix 
kit (Intron Biotech).  Information regarding the primer sequences and detailed PCR conditions for each 
tested region are provided as Appendix A.  
The amplified PCR products were analyzed using restriction enzyme digestion (COBRA) (Xiong 
and Laird, 1997).  Each PCR product was analyzed with two sets of restriction enzymes.  First, the 
efficiency of the bisulfite conversion reaction was monitored with a set of enzymes that contain non-CpG 
cytosines in their recognition sites (DdeI, HpaII).  Any digestion by these enzymes indicates that the 
conversion reaction was incomplete.  A second set of enzymes that distinguish between unmethylated and 
methylated DNA were chosen to analyze the degree of methylation in each tested region.  The recognition 
site of each of these enzymes contains a CpG site (TaqI, BstUI, and HpyCH4IV).  Since methylation 
inhibits the conversion of cytosines into thymidines during the bisulfite conversion, digestion by these 
enzymes indicates methylation on a given CpG site in vivo.  Each of these restriction digestion reactions 
was repeated at least three times.  
Selected PCR products amplified from the bisulfite-treated DNA were further analyzed through 
cloning and sequencing.  Each of the selected PCR products was purified using the MEGA-Spin agarose 
gel purification kit (Intron), and then individually cloned into the pGEM-tEasy vector (Promega).  At least 
10 different clones were randomly selected for DNA sequencing for each PCR product.  Unincorporated 
primers and dye terminators were removed via ethanol precipitation, and an ABI 3130 XL was used to 
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analyze the results.  To determine methylation status, the resulting electropherograms were visually 
inspected in BioEdit (Hall, 1999).  
RT PCR 
Normalized cDNA from the human brain, heart, kidney, liver, and placenta was obtained from Biochain.   
RT-PCR was performed using the Maxime PCR premix kit (Intron Biotech) using an annealing 
temperature of 56 °C and 38 cycles.   
cDNA Cloning 
Human brain and testis RNA were obtained from a commercial firm (Biochain).  Brain and testis RNA (5 
µg) were converted to cDNA using the Superscript III First-Strand Synthesis System (Invitrogen).  PCR 
products amplified using the Zim2as-a and Zim2as-b2 primers were cloned into the pGEM-T Easy vector 
(Promega).  Seven colonies were picked, plasmid DNA was isolated using the DNA-spin kit (Intron 
Biotech), and sequenced using BigDye v3.1 (Applied Biosystems).  Unincorporated primers and dye 
terminators were removed via ethanol precipitation, and the ABI 3130 XL was used to analyze the results. 
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CHAPTER FOUR: CONCLUSIONS 
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Most genes are expressed from two parental alleles, but a few are expressed only from one allele 
due to the genomic imprinting process, which selectively silences one allele based on the parent of origin 
(Ideraabdullah et al., 2008).  Imprinted genes are mainly found in clusters, where the imprinting of several 
genes is coordinately controlled by an imprinting control region (ICR) (Edwards and Ferguson-Smith, 
2007).  Imprinted clusters have a few features in common: differentially methylated regions (DMRs), 
regions of sequence methylated only on one parental allele, and antisense transcripts (Ferguson-Smith et 
al., 2004; Pauler et al., 2007).  Both of these features play a role in regulating expression of the genes in 
the imprinted cluster.  Imprinting can have an immediate effect on health because the genes are 
effectively hemizygous, so mutations in the expressed allele have the same effect as a dominant mutation.  
In addition, many imprinted genes have been implicated in cancer formation, consistent with the fact that 
many of these genes are involved in growth (Tilghman, 1999).  The Peg3 imprinted domain is a region 
specific to placental mammals, and its overall organization is conserved among all mammals (Kim and 
Stubbs, 2005).  Several genes in this region have been shown to be imprinted in the mouse and cow (Kim 
et al., 2007).  The imprinting and expression pattern of the Peg3 gene itself has been studied in detail in 
several species including human.  Here we present the first systematic analysis of DNA methylation over 
this entire region.  This analysis of the “normal” methylation patterns in this domain provides a 
foundation for future studies of possible changes in the epigenetic status of this region in disease or after 
exposure to various environmental factors.   
In chapter two, we describe a survey of the DNA methylation status of the CpG islands in the 
Peg3 imprinted domain in human normal and tumor samples, several developmental stages of the mouse, 
and the adult cow.  Our study revealed several interesting features of this domain. In terms of sequence 
characteristics, we found that this domain contains more CpG islands and tandem repeats (both within 
CpG islands and in the greater region) than a nonimprinted region containing similar types of genes.  The 
prevalence of these two features may be linked.  CpG islands have a high mutation rate due to 
spontaneous deamination of methylated cytosines to produce thymine.  Tandem repeats are often present 
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within CpG islands and are especially enriched in imprinted regions (Hutter et al., 2006).  Creating 
tandemly repeated arrays of a CpG island would preserve its functionality if there is some threshold size 
required for a CpG island to be relevant to gene expression.  Also, we found fewer LINEs in this region 
than the reference region.  This is the opposite result from that found by Allen et al., which found 
enrichment of LINEs in imprinted regions.  This result cannot be explained simply by base composition, 
since the Peg3 imprinted region and the reference region are similar in this respect.  Thus, this may be a 
specific feature of the Peg3 imprinted domain.  On the other hand, this could be an effect of the relatively 
small (compared to the entire genome) region of sequence studied.   
After analyzing the sequence characteristics of this region, we analyzed the DNA methylation 
status of the predicted CpG islands that were associated with genes since these were most likely to be 
relevant to their expression.  We found that the Peg3-CpG island was a DMR in adult tissues of all three 
species studied, and it was hypermethylated in human ovarian tumor DNA.  We also identified two 
previously unreported DMRs in the Peg3 imprinted domain.  The Zim3-CpG island is a DMR in the 
mouse, but this methylation status is not shared with human (unmethylated) or cow (completely 
methylated).  In addition, we discovered a new possible tissue-specific DMR at the human USP29-CpG 
island, which showed a mosaic pattern of methylation in the human brain and was comparatively 
hypomethylated  in normal testis DNA, but was hypermethylated in breast and ovarian tumor DNA.  The 
Zim1-CpG island lacked methylation in all of the samples studied (sperm, ES cell, placenta, and adult 
liver).   
This was an unexpected result, since Zim1 is a maternally expressed gene (Kim et al., 1999).  
Since Zim1 is most highly expressed around embryonic day 14, differential methylation might be present 
at this stage.  The lack of methylation in the adult could be explained by the lack of maintenance of the 
mark past this stage, effectively passively demethylating this region.  However, the imprint could also be 
regulated through other epigenetic mechanisms, such as histone modifications.  To discover what 
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mechanism controls the imprinting of this gene, samples from this developmental stage should be 
analyzed for both DNA methylation levels and chromatin modifications. 
 The Peg3-CpG island was a DMR in adult tissues of all three species studied.  As expected based 
on the results of previous studies (Li et al., 2000), the mouse germline samples showed that methylation 
was present only on the maternal allele at this stage.  This pattern continued throughout the blastocyst, ES 
cell, placenta, and adult samples tested.  In the human, we saw the same pattern in DNA derived from 
normal brain and testis tissues as well as in breast tumor DNA.  However, the PEG3-CpG island was 
hypermethylated (80% methylated) in human ovarian tumor DNA.  PEG3 expression is reduced by the 
hypermethylation of its promoter CpG island in gliomas and ovarian tumors (Maegawa et al., 2001; Feng 
et al., 2008).  Since Peg3 knockout mice have not been reported to show more tumor development than 
wild type mice, Peg3 is probably not involved in the initiation of cancer (Li et al., 1999).  It is probably 
either methylated as an indirect effect of an oncogene, or is shut off in the later phases of the 
establishment of a tumor.  Inactivation of Peg3 could potentially give cancer a growth advantage since 
this protein has been shown to promote apoptosis subsequent to p53 activation (Deng and Wu, 2000). 
We also identified two previously unreported DMRs in the Peg3 imprinted domain.  The Zim3-
CpG island is also a DMR in the mouse, but this methylation status is not shared with human 
(unmethylated) or cow (completely methylated).  This species-specific DNA methylation pattern indicates 
that the Zim3-CpG island is possibly less constrained, or that Zim3 plays a different role in each animal.  
Changes in DNA methylation status could possibly happen faster than sequence divergence, so these 
species-specific changes could play a role in the evolution of the species.  Compared to the Peg3-CpG 
island, the Zim3-CpG island showed an interesting pattern of methylation acquisition.  This CpG island is 
an interesting example of a region with parental allele-specific methylation that is not set in the germline.  
The methylation on the Peg3-CpG island was established on the maternal allele and remained there 
throughout development (germline DMR).  However, the Zim3-CpG island was unmethylated in the 
sperm sample, but methylation was found specifically on the paternal allele in the adult.  This swap 
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implies that the DNA methylation was reset after fertilization and then directed to the paternal allele 
(somatic DMR).  This is consistent with the fact that Zim3 is maternally expressed (Kim et al., 2001).  
The methylation pattern on the Zim3-DMR is probably established directly by the ICR of the Peg3 
imprinted domain, but may be an indirect effect of the methylation pattern of Usp29.  In other words, the 
Peg3-ICR may be responsible for setting the methylation status of Usp29, which in turn sets the pattern of 
Zim3. In mice the Usp29 and Zim3 transcripts overlap and are antisense to each other (Fig. 4.1).  Thus, 
the presence of transcription machinery on one of these genes would physically block transcription of the 
other.  Also, the antisense transcript might direct repressive modifications to the sense promoter. 
 
Figure 4.1 Expression patterns of Peg3, Usp29, and Zim3.  
A schematic of mouse chromosome 7 between Peg3 and Zim3.  The maternal and paternal copies are 
displayed separately and indicated by their respective symbols.  The direction of each arrow indicates the 
direction of transcription, and an x over an arrow indicates that that transcript is not expressed. 
 
In addition, we discovered a new possible tissue-specific DMR at the human USP29-CpG island, 
which showed a mosaic pattern of methylation (54.5% methylated) in the human brain and was 
hypomethylated (26.3% methylated) in normal testis DNA.  This CpG island showed hypermethylation in 
both breast (81.8% methylated) and ovarian (65.5% methylated) tumor DNA.  Overall, two CpG islands 
in the Peg3 imprinted domain were found to be hypermethylated in two types of human cancer genomic 
DNA.  This would most likely result in repression of the associated genes.  Future studies of this region 
should survey a greater range of cancer types to see if the hypermethylation and/or repression of PEG3 
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and USP29 only occurs in certain types of cancers or if it is a general pattern.  In addition, it would be 
interesting to determine at what point of cancer progression PEG3 and USP29 become hypermethylated.  
If this can be determined, hypermethylation of these genes could be used as a marker for the progression 
of a cancer. 
In chapter three, we describe a transcript antisense to ZIM2 in the great apes.  This transcript spans 
the region from the first intron of ZNF835 to the fourth from last intron of ZIM2 and is expressed in 
human brain and testis.  We tested the DNA methylation status of several CpG islands surrounding 
ZIM2as, including two CpG islands in its promoter region.  This investigation revealed a species-specific 
methylation pattern.  The CpG island farthest from the start site of ZIM2as is a human testis-specific 
DMR, but is methylated in the chimpanzee.  The CpG island proximal to ZIM2as shows a mosaic pattern 
of methylation in the chimpanzee, but it was unmethylated in the human.  The differences between DNA 
methylation in the human and chimpanzee represent the ability of DNA methylation to provide a source 
of variation beyond nucleotide sequence, since there is 99% sequence identity between these two species.  
Both CpG islands associated with ZIM2as were methylated in the rhesus macaque.  The complete 
methylation of both of these CpG islands in the rhesus macaque is most likely because this region is 
simply an intron sequence in this species.  Several of the CpG islands on the 5` side of ZIM2as (those 
associated with ZNF 470, ZNF71, ZNF471, ZNF28) were unmethylated in all three species.  We tested 
two CpG islands on the 3` side of ZIM2as and found that the PEG3-CpG island was a DMR in all three 
species.  However, the ZIM3-CpG island showed a DMR-like pattern in the rhesus, but was unmethylated 
in both human and chimpanzee.  This DMR pattern is similar to the pattern found in the mouse, which 
may indicate that the presence of ZIM2as in the great apes can affect some of the nearby genes in the 
imprinted domain.  An alternative explanation for the methylation changes seen here is the fact that both 
the rhesus and chimpanzee DNA samples are from cultured cell lines.  Prolonged growth in cell culture 
has been shown to alter methylation patterns (Chang et al., 2009).  However, it is rather unlikely that this 
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is the source of these differences since the methylation patterns of DNA from two different human tissues 
and both of the primate cell lines are identical in four surrounding regions.    
In most mammals, the Peg3 imprinted domain is flanked by a cluster of olfactory receptor genes 
on one end and a cluster of vomeronasal organ receptor genes on the other.  This cluster of olfactory 
receptor genes is present in all the non-primate mammals for which we could obtain genome sequences, 
including the mouse, cow, and dog.  Since these types of gene clusters often have insulator or barrier 
functions (Valenzuela and Kamakaka, 2006), the clusters flanking the Peg3 region probably delineate the 
boundaries of this imprinted domain in most mammals.  However, these gene clusters are not found in the 
rhesus macaque, orangutan, chimpanzee, or human (the only primates for which there are genome 
sequences of sufficient coverage available).  It is possible that the loss of this particular cluster on the 5’ 
side of the primate PEG3 imprinted domain may result in spreading of imprinting to more distant regions.  
Another interesting difference in the primate Peg3 region is the presence of a transcript oriented antisense 
to ZIM2 (ZIM2as) in the human, chimpanzee, and orangutan genomes.  The majority of its coding 
sequence is absent from the rhesus macaque genome.  The fact that all primates analyzed lack the 
olfactory receptor cluster while only humans, chimpanzees, and orangutans have the antisense transcript 
suggests that ZIM2as formed after the deletion.  Alternatively, the olfactory cluster deletion and ZIM2as 
formation might have been simultaneous, and the rhesus may have undergone a lineage-specific deletion 
of ZIM2as.  Completion and assembly of the marmoset genome sequence should provide some insight 
into the true sequence of the genomic rearrangements in the primate PEG3 imprinted domain.   
Overall, it seems that the formation of ZIM2as in the great apes is associated with several changes 
in DNA methylation, including allele-specific methylation in the human testis.  This antisense transcript 
gene is most likely imprinted in the humans based on the allele-specific DNA methylation observed from 
the human testis sample.  We also predict that this antisense transcript gene is imprinted in other primates 
based on the patterns observed from similar antisense transcripts in other imprinted domains 
(Ideraabdullah et al., 2008).  If it is the case that ZIM2as is imprinted, it will be interesting to test if the 
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PEG3 imprinted domain has indeed expanded in the primate lineage.  In particular, it would be of great 
interest to investigate the potential imprinting of several zinc finger genes located in the region 
immediately adjacent to ZIM2as, in particular ZNF835.  Since ZIM2as spans both this gene and ZIM2, it 
may regulate the expression of either or both of these transcripts (Fig 4.2). 
 
Figure 4.2.  Expression patterns of ZNF835, ZIM2as, and PEG3/ZIM2. 
A schematic of allele-specific expression on human chromosome 19 between ZNF835 and PEG3.  The 
maternal and paternal copies are displayed separately and indicated by their respective symbols.  The 
direction of each arrow indicates the direction of transcription, and an x over an arrow indicates that that 
transcript is not expressed. 
 
If ZIM2as does function similarly to antisense transcripts found in other imprinted domains, one of its 
roles would be the establishment and maintenance of imprinting of this region (Ideraabdullah et al., 2008; 
Bertaux et al., 2008).  It might be also involved in maintaining the imprinting of the expanded Peg3 
domain.  In the future it will be interesting to analyze changes in chromatin modifications and expression 
status of the genes surrounding ZIM2as. 
This dissertation represents the first systematic study of DNA methylation in the Peg3 imprinted 
region in the adult human as well as in several developmental stages in the mouse (sperm, oocyte, 
blastocyst, ES cell, placenta, and adult liver).  It also describes an antisense transcript that has formed in 
the great ape PEG3 imprinted domain which may control the extension of this imprinted domain.  The 
results of these studies provide a firm foundation upon which future studies of this imprinted domain can 
rest.  Although it was only possible to study DNA methylation in relatively short stretches of sequence in 
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these studies, advances in technology should soon make the study of DNA methylation across this domain 
feasible and aid in the determination of the exact extent of the imprinted domain.   
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Bisulfite primer information for analysis of the PEG3 imprinted region in the human, mouse, and 
cow. 
O
rganism
 
Prim
er 
Sequence 
A
nnealing tem
p. 
(°C
) 
R
estriction enzym
e 
to analyze 
m
ethylation 
R
estriction enzym
e 
to m
onitor bisulfite 
conversion 
human hZNF264-bis-1 gtttttgtttgtgttttgatttgaaggaaag 60 HpyCH4IV HpaII 
 hZNF264-bis-2.1 aaccctcaataactacaaacctctccaaac 
 hUSP29-bis-5 gttyggtttgtagatttgattttggtagt 60 TaqI HpaII 
 hUSP29-bis-6.1 cttaaaccttcaaacrtatttacctcaacc 
 hZIM3-bis-1 ggttgaagtaggtagattattagaggttag 60 BstUI HpaII 
 hZIM3-bis-2.1 ctaatacttacctcattatctttacacaaac 
 hDUXA-bis-5 ggttaggtaagttttagtagaattaattag 60 HpyCH4IV DdeI 
 hDUXA-bis-6 aattcataccattctcctacctcaacctcc 
 hDUXA-bis-3 atgttagagtaaggtagggttttgtatttg 60 TaqI HpaII 
 hDUXA-bis-4 ccattcaattaactaaaaacttaaaattta 
 hPEG3-bis-3 gtattttgtggtgaataaagttttggttag 58 HpyCH4IV HpaII 
 hPEG3-bis-4 cccacctaaataccatctttaatcraaac 
 hZNF835-3 tggtgtagggttaggtgtacgttttggttga 60 HpyCH4IV HpaII 
 hZNF835-4 craaccctactactacccaaaccaatatc 
 hH19-bis-3 gtgtttgatttattttagggtgtattgt 60 TaqI HpaII 
 hH19-bis-4 actcctataaatatcctattcccaaataac 
 hZNF71-bis-5 agttttttgtgagatggaggagtttagttg 62 TaqI HpaII 
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 hZNF71-bis-6 cctcatcctcaaaataatatacactaccta 
cow cPeg3-bis-5 tattgttgttattaaggagttgtttgtttt 60 BstUI DdeI 
 cPeg3-bis-6 ctcaacctatctatcaacaaactacaataa 
 cZim3-bis-3 gtaagagttgaggagttgtagtttagtagg 60 ClaI HpaII 
 cZim3-bis-4 ccaatatcaacccctatactataatcatac 
 cZim2-bis-5 gaagatttttgagagttttttagattgtaaga 58 BstUI HpaII 
 cZim2-bis-6 ttttcctctaaaccccaaactatattaact 
 cAst1-bis-5 agggtttaaggatataaatatatttgtaga 58 HhaI HpaII 
 cAst1-bis-6 atacraaaattactttaaaaaataaaaaac 
 cUsp29-bis-5 gtgtatataaaagaagatatatttagtgtga 56 TaqI HpaII 
 cUsp29-bis-6 aactcataaaaacaaaattccaaaaaatct 
mouse mPeg3-met-15 aggaagagttagaggagttagtattttataga 60 HphI, BstUI DdeI 
 mPeg3-met-16.1 cctattacaaaaccaccacaataaacatca 
 mPeg3-met-15.2 taggtagttaattaggataagtttgtgtag 
 mZim1-met-3 gtagtagaagtatgtttaagagttgtgtta 58 HhaI HpaII 
 mZim1-met-4 cttactaaaaactacatttcccacaaatcc 
 mZim2-met-3 gtataatatattataggattttatgttatt 55 TaqI DdeI  
 mZim2-met-4 atataacaactcttcaataaattaaaacat 
 mZim2-met-5 gatattttaatatttatttggttttttgaa 55 TaqI DdeI 
 mZim2-met-6 aattacttacatcaatactacctctaaaac 
 mZim3-met-3 tatatttgaaagaaattgggatttttaa 58 BstUI DdeI 
 mZim3-met-4 accactaactacccttaactactacaaact 
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DNA Methylation analysis of Peg3 and Usp29 in human matched-pair lung and liver samples 
 
COBRA data from human matched pair DNA.  Lanes labeled U indicate undigested DNA, and lanes 
labeled C indicate digested DNA.  The enzyme with which each sample was incubated is indicated to the 
right of the figure.  The arrows labeled U and M indicate the position of unmethylated and methylated 
DNA, respectively.   There is no difference in the methylation levels of the PEG3-CpG island and the 
USP29-CpG island between the different tissues or between normal and tumor tissues.  
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Zim2as Exon Structure 
Feature 
Size 
(bp) 
Exon 1  50 
Intron 1  11870 
Exon 2  74 
Intron 2  25430 
Exon 3  53 
Intron 3  80072 
Exon 4  151 
Intron 4  977 
Exon 5  240 
     
Transcript Length  568 
Genomic DNA 
Span  118917 
 
RT-PCR primer information for analysis of transcripts surrounding ZIM2as in the human. 
Locus 
Prim
er N
am
e 
Prim
er 
Sequence 
A
nnealing 
Tem
p 
PEG3 hPEG3rt-1 aagagaagtgcctacccaagc 56 
 hPEG3rt-2 aacctaaagcctcccctaaatg  
ZNF835 hZNF835rt-3 gttggaaggaaactggaaacac 56 
 hZNF835rt-4 tggtgtaagatgaacgctgaac  
GAPDH hGAPDHrt-1 gcaggggggagccaaaaggg 56 
 hGAPDHrt-2 tgccagccccagcgtcaaag  
ZIM2 ZIM2rt-1 cttaggaacatttctggtgtttgag 56 
 ZIM2rt-2 gtcttggggtcattcattgttatag  
ZIM2as ZIM2as-a gaggttcagacaggctaagtccctac 56 
 ZIM2as-b2 ccaggagacagaggcataaagaggt  
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Bisulfite primer information for analysis of the ZIM2as region in the human, chimpanzee, and 
rhesus macaque. 
 
 
 
O
rganism
 
Prim
er N
am
e 
Prim
er 
Sequence 
A
nnealing 
Tem
p 
R
estriction 
enzym
e to 
m
onitor 
bisulfite 
conversion
R
estriction 
enzym
e to  
analyze 
m
ethylation 
Human 
hPEG3-bis-3 gtattttgtggtgaataaagttttggttag 
58 HpaII HpyCH4 IV hPEG3-bis-4 cccacctaaataccatctttaatcraaac 
ptZim3-bis-1 ttttagtattttgggaggttaaggtagg 
58 HpaII BstUI ptZim3-bis-2 caactacttcaaaattcataatttctactc 
hZNF71-bis-5 agttttttgtgagatggaggagtttagttg 
60   TaqI hZNF71-bis-6 cctcatcctcaaaataatatacactaccta 
hZNF470-bis-1 ggattatattttttaggggttattgtag 
60 HpaII TaqI hZNF470-bis-2 aaccacttaaaatacttcactcattcca 
hZNF835-3 tggtgtagggttaggtgtacgttttggttga 
60 HpaII HpyCH4 IV hZNF835-4 craaccctactactacccaaaccaatatc 
hZIM2as-bis-1 agacgagttaaggttaagatttttgttgttg 
58 HpaII HpyCH4 IV hZIM2as-bis-2.1 caaaaaaaaaatcccacccctaaattacta 
Chimpanzee 
hPEG3-bis-3 gtattttgtggtgaataaagttttggttag 
58 HpaII HpyCH4 IV hPEG3-bis-4 cccacctaaataccatctttaatcraaac 
ptZim3-bis-1 ttttagtattttgggaggttaaggtagg 
58 HpaII BstUI ptZim3-bis-2 caactacttcaaaattcataatttctactc 
PtZnf71-bis-1 gtttttgtgagatggaggagtttagtt 
60   TaqI PtZnf71-bis-2 ccccaaaataaccctaatattcataca 
ptZnf470-bis-1 ggattatattttttaggggttattg 
60 HpaII TaqI ptZnf470-bis-2 aaccacttaaaatacttcactcattcc 
hZNF835-3 tggtgtagggttaggtgtacgttttggttga 
58 HpaII 
BstUI/HpyCH4 
IV hZNF835-4 craaccctactactacccaaaccaatatc 
ptZim2as-bis-1 gtagttagtaatttaggggtgggaatt 
60 HpaII HpyCH4 IV ptZim2as-bis-2 acctatctaaacctcaacttccttctt 
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Rhesus 
Macaque 
rhPeg3-bis-5 ttagataataataggggaaggggtgag 
58   HpyCH4 IV rhPeg3-bis-6 ccrcctaaatataaaattatccacaaaaa 
rhZim3-bis-5 aatgaaaaggtatgtgtagtaggattagt 
58 HpaII BstUI rhZim3-bis-6 aaccaattaaattttaaccattcrtctaac 
rhZnf71-bis-3 tttgggagttagaggagtttagttggttttg 
62   TaqI rhZnf71-bis-4 ataccctaaacctacccccaaccctacact 
rhZnf470-bis-1 ttttagttttgttttattgtttttgtatattt 
60   HpyCH4 IV rhZnf470-bis-2 tactaccctatatcctcttttaaacctctc 
rhZnf835-bis-1 gagttttggttgaaggttttgttatat 
58 HpaII TaqI/HpyCH4 IVrhZnf835-bis-2 ccctactactacccaaaccaatatc 
rhZim2as-bis-1 ttaggagaatttttagatttgtttaaagtt 
60   HpyCH4 IV rhZim2as-bis-2 ataccaacccatcactatatctacaca 
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